Views from Multidisciplinary Oncology Clinicians on Strengthening Cancer Care Delivery Systems in Tanzania.
Africa
Cancer care facilities
Guideline adherence
Implementation science
Low- and middle-income countries
Quality improvement
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
24
12
2020
accepted:
14
05
2021
pubmed:
28
5
2021
medline:
13
7
2021
entrez:
27
5
2021
Statut:
ppublish
Résumé
In response to the increasing burden of cancer in Tanzania, the Ministry of Health, Community Development, Gender, Elderly and Children launched National Cancer Treatment Guidelines (TNCTG) in February 2020. The guidelines aimed to improve and standardize oncology care in the country. At Ocean Road Cancer Institute (ORCI), we developed a theory-informed implementation strategy to promote guideline-concordant care. As part of the situation analysis for implementation strategy development, we conducted focus group discussions to evaluate clinical systems and contextual factors that influence guideline-based practice prior to the launch of the TNCTG. In June 2019, three focus group discussions were conducted with a total of 21 oncology clinicians at ORCI, stratified by profession. A discussion guide was used to stimulate dialogue about facilitators and barriers to delivery of guideline-concordant care. Discussions were audio recorded, transcribed, translated, and analyzed using thematic framework analysis. Participants identified factors both within the inner context of ORCI clinical systems and outside of ORCI. Themes within the clinical systems included capacity and infrastructure, information technology, communication, efficiency, and quality of services provided. Contextual factors external to ORCI included interinstitutional coordination, oncology capacity in peripheral hospitals, public awareness and beliefs, and financial barriers. Participants provided pragmatic suggestions for strengthening cancer care delivery in Tanzania. Our results highlight several barriers and facilitators within and outside of the clinical systems at ORCI that may affect uptake of the TNCTG. Our findings were used to inform a broader guideline implementation strategy, in an effort to improve uptake of the TNCTGs at ORCI. This study provides an assessment of cancer care delivery systems in a low resource setting from the unique perspectives of local multidisciplinary oncology clinicians. Situational analysis of contextual factors that are likely to influence guideline implementation outcomes is the first step of developing an implementation strategy for cancer treatment guidelines. Many of the barriers identified in this study represent actionable targets that will inform the next phases of our implementation strategy for guideline-concordant cancer care in Tanzania and comparable settings.
Sections du résumé
BACKGROUND
In response to the increasing burden of cancer in Tanzania, the Ministry of Health, Community Development, Gender, Elderly and Children launched National Cancer Treatment Guidelines (TNCTG) in February 2020. The guidelines aimed to improve and standardize oncology care in the country. At Ocean Road Cancer Institute (ORCI), we developed a theory-informed implementation strategy to promote guideline-concordant care. As part of the situation analysis for implementation strategy development, we conducted focus group discussions to evaluate clinical systems and contextual factors that influence guideline-based practice prior to the launch of the TNCTG.
MATERIALS AND METHODS
In June 2019, three focus group discussions were conducted with a total of 21 oncology clinicians at ORCI, stratified by profession. A discussion guide was used to stimulate dialogue about facilitators and barriers to delivery of guideline-concordant care. Discussions were audio recorded, transcribed, translated, and analyzed using thematic framework analysis.
RESULTS
Participants identified factors both within the inner context of ORCI clinical systems and outside of ORCI. Themes within the clinical systems included capacity and infrastructure, information technology, communication, efficiency, and quality of services provided. Contextual factors external to ORCI included interinstitutional coordination, oncology capacity in peripheral hospitals, public awareness and beliefs, and financial barriers. Participants provided pragmatic suggestions for strengthening cancer care delivery in Tanzania.
CONCLUSION
Our results highlight several barriers and facilitators within and outside of the clinical systems at ORCI that may affect uptake of the TNCTG. Our findings were used to inform a broader guideline implementation strategy, in an effort to improve uptake of the TNCTGs at ORCI.
IMPLICATIONS FOR PRACTICE
This study provides an assessment of cancer care delivery systems in a low resource setting from the unique perspectives of local multidisciplinary oncology clinicians. Situational analysis of contextual factors that are likely to influence guideline implementation outcomes is the first step of developing an implementation strategy for cancer treatment guidelines. Many of the barriers identified in this study represent actionable targets that will inform the next phases of our implementation strategy for guideline-concordant cancer care in Tanzania and comparable settings.
Identifiants
pubmed: 34041817
doi: 10.1002/onco.13834
pmc: PMC8265360
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1197-e1204Subventions
Organisme : FIC NIH HHS
ID : D43 TW009333
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009343
Pays : United States
Informations de copyright
© 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.
Références
Lancet. 2010 Oct 2;376(9747):1186-93
pubmed: 20709386
J Glob Oncol. 2016 May 25;2(5):311-340
pubmed: 28717717
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Health Serv Res. 1999 Dec;34(5 Pt 2):1189-208
pubmed: 10591279
J Med Trop. 2012;14(1):1-6
pubmed: 25243111
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Natl Compr Canc Netw. 2016 Aug;14(8):961-9
pubmed: 27496112
Cancer. 2020 May 15;126 Suppl 10:2394-2404
pubmed: 32348574
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Breast J. 2006 Jan-Feb;12 Suppl 1:S3-15
pubmed: 16430397
J Glob Oncol. 2018 Sep;4:1-10
pubmed: 30241222
Cancer. 2020 May 15;126 Suppl 10:2405-2415
pubmed: 32348576
J Glob Oncol. 2019 Mar;5:1-8
pubmed: 30943098
Breast Cancer (Auckl). 2014 May 08;8:73-9
pubmed: 24855371
J Glob Oncol. 2019 Jul;5:JGO1800052
pubmed: 31343933
Oncologist. 2019 Jan;24(1):69-75
pubmed: 29934410
J Glob Oncol. 2019 Nov;5:1-10
pubmed: 31702947
Gynecol Oncol Rep. 2019 May 21;29:40-47
pubmed: 31309135
BMC Public Health. 2020 Jun 15;20(1):930
pubmed: 32539723
Implement Sci Commun. 2020 Feb 25;1:24
pubmed: 32885183
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818